Amneal Pharmaceuticals, Inc. (AMRX) Stock

Amneal Pharmaceuticals, Inc. (AMRX) is a Healthcare stock trading at $16.20 (as of 2026-06-18), with a market capitalization of $4.11B and a trailing P/E of 43.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products across multiple dosage forms and therapeutic areas. It operates through Generics, Specialty, and AvKARE segments, including branded products and specialty therapies, and AvKARE’s supply of pharmaceuticals and related medical products to government and defense and veterans’ agencies.

Valuation — source: SEC EDGAR (first-party)
Price$16.20
Market Cap$4.11B
P/E Ratio43.8
EV / EBITDA15.3
Price / Book-112.43
Price / Sales1.70
DCF Value (model)$9.68
DCF Upside vs Price-40.3%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$3.02B
Net Margin2.4%
Return on Equity-265.7%
Debt / Equity-55.95
Current Ratio2.47
Revenue Growth (YoY)3.9%
EPS Growth (YoY)400.0%
FCF Growth (YoY)506.8%
Financial Health — source: SEC EDGAR
Altman Z-Score2.12 (grey)
Piotroski F-Score7/9 (strong)
Valuation vs Sector & Industry
Stock P/E43.8
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector108.9%
vs Industry153.7%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($304.77M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOChirag K. Patel
Employees8,300
CountryUS
IPO Date2018-05-07

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Indivior Pharmaceuticals Inc (INDV)
  • ACADIA Pharmaceuticals Inc. (ACAD)
  • Crinetics Pharmaceuticals, Inc. (CRNX)
  • ADMA Biologics, Inc. (ADMA)
  • Mirum Pharmaceuticals, Inc. (MIRM)
  • NewAmsterdam Pharma Company N.V. (NAMS)
  • Ligand Pharmaceuticals Incorporated (LGND)
  • Corcept Therapeutics Incorporated (CORT)
AMRX earnings history · AMRX institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.